Current List of Clinical Trials
Clinical Research Office
Jeanine Secor, RN, BSN, CCRP 561-263-5791 | Estelle Hansen, RN, BSN 561-263-5768 | Michelle Drys, MBA 561-263-3689 |
NEW STUDY - Lung Surgery NEO12-102 BARD
Date:
February 21, 2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracic Surgery.
Multiple Cancer Sites ADEPT-001-01 Adept Bio., Any treatment ok / neoadjuvant ok
Date:
February 21, 2013
Procurement of Human Biospecimens for Research
Research Supplied: None
Research Supplied: None
Head & Neck ECOG E1305 MSCCOP, 1st line / metastatic
Date:
February 21, 2013
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
Research Supplied: Bevacizumab
Research Supplied: Bevacizumab
Melanoma (Adjuvant Resected High Risk) CTSU E1609 MSCCOP, 1st line / adjuvant
Date:
February 21, 2013
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon ?-2b for Resected High-Risk Melanoma
Research Supplied: Ipilimumab
Research Supplied: Ipilimumab
Lung JMC-OPKO-001 OPKO Health, 1st line / neoadjuvant
Date:
February 21, 2013
Biomarker Development for Lung Cancer: Collection of Serum from Persons Undergoing Diagnostic Lung Biopsy
Lung E1505 MSCCOP, 1st line / adjuvant
Date:
February 21, 2013
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (≥4cm)-IIIA Non-Small Cell Lung Cancer (NSCLC)
Research Supplied: Bevacizumab
Research Supplied: Bevacizumab
Renal Cell SWOG S0931 MSCCOP, 1st line / adjuvant
Date:
February 21, 2013
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.
Research Supplied: Everolimus/Placebo
Research Supplied: Everolimus/Placebo
TCC CALGB 90601 MSCCOP, 1st line / metastatic
Date:
February 21, 2013
A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma
Research Supplied: Bevacizumab
Research Supplied: Bevacizumab
Adenocarcinoma of the Ovary, Peritoneum or Fallopian Tube GOG 0273 MSCCOP 1st line / adjuvant
Date:
February 21, 2013
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
IV Anti-Emetic During Moderately Emetogenic Chemotherapy Merck 1st Line
Date:
February 21, 2013
A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of a Single 150 mg Dose of Intravenous Fosaprepitant Dimeglumine